208 related articles for article (PubMed ID: 8889898)
1. Midazolam hydroxylation by human liver microsomes in vitro: inhibition by fluoxetine, norfluoxetine, and by azole antifungal agents.
von Moltke LL; Greenblatt DJ; Schmider J; Duan SX; Wright CE; Harmatz JS; Shader RI
J Clin Pharmacol; 1996 Sep; 36(9):783-91. PubMed ID: 8889898
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of terfenadine metabolism in vitro by azole antifungal agents and by selective serotonin reuptake inhibitor antidepressants: relation to pharmacokinetic interactions in vivo.
von Moltke LL; Greenblatt DJ; Duan SX; Harmatz JS; Wright CE; Shader RI
J Clin Psychopharmacol; 1996 Apr; 16(2):104-12. PubMed ID: 8690825
[TBL] [Abstract][Full Text] [Related]
3. Effect of fluoxetine, norfluoxetine, sertraline and desmethyl sertraline on human CYP3A catalyzed 1'-hydroxy midazolam formation in vitro.
Ring BJ; Binkley SN; Roskos L; Wrighton SA
J Pharmacol Exp Ther; 1995 Dec; 275(3):1131-5. PubMed ID: 8531073
[TBL] [Abstract][Full Text] [Related]
4. Inhibition and kinetics of cytochrome P4503A activity in microsomes from rat, human, and cdna-expressed human cytochrome P450.
Ghosal A; Satoh H; Thomas PE; Bush E; Moore D
Drug Metab Dispos; 1996 Sep; 24(9):940-7. PubMed ID: 8886602
[TBL] [Abstract][Full Text] [Related]
5. Venlafaxine: in vitro inhibition of CYP2D6 dependent imipramine and desipramine metabolism; comparative studies with selected SSRIs, and effects on human hepatic CYP3A4, CYP2C9 and CYP1A2.
Ball SE; Ahern D; Scatina J; Kao J
Br J Clin Pharmacol; 1997 Jun; 43(6):619-26. PubMed ID: 9205822
[TBL] [Abstract][Full Text] [Related]
6. Midazolam alpha-hydroxylation by human liver microsomes in vitro: inhibition by calcium channel blockers, itraconazole and ketoconazole.
Wang JS; Wen X; Backman JT; Taavitsainen P; Neuvonen PJ; Kivistö KT
Pharmacol Toxicol; 1999 Oct; 85(4):157-61. PubMed ID: 10563513
[TBL] [Abstract][Full Text] [Related]
7. Inhibition by fluoxetine of cytochrome P450 2D6 activity.
Otton SV; Wu D; Joffe RT; Cheung SW; Sellers EM
Clin Pharmacol Ther; 1993 Apr; 53(4):401-9. PubMed ID: 8477556
[TBL] [Abstract][Full Text] [Related]
8. O-Dealkylation of fluoxetine in relation to CYP2C19 gene dose and involvement of CYP3A4 in human liver microsomes.
Liu ZQ; Zhu B; Tan YF; Tan ZR; Wang LS; Huang SL; Shu Y; Zhou HH
J Pharmacol Exp Ther; 2002 Jan; 300(1):105-11. PubMed ID: 11752104
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of cytochrome P-450 3A (CYP3A) in human intestinal and liver microsomes: comparison of Ki values and impact of CYP3A5 expression.
Gibbs MA; Thummel KE; Shen DD; Kunze KL
Drug Metab Dispos; 1999 Feb; 27(2):180-7. PubMed ID: 9929500
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of alprazolam and desipramine hydroxylation in vitro by paroxetine and fluvoxamine: comparison with other selective serotonin reuptake inhibitor antidepressants.
von Moltke LL; Greenblatt DJ; Court MH; Duan SX; Harmatz JS; Shader RI
J Clin Psychopharmacol; 1995 Apr; 15(2):125-31. PubMed ID: 7782485
[TBL] [Abstract][Full Text] [Related]
11. Interindividual variability in catalytic activity and immunoreactivity of three major human liver cytochrome P450 isozymes.
Transon C; Lecoeur S; Leemann T; Beaune P; Dayer P
Eur J Clin Pharmacol; 1996; 51(1):79-85. PubMed ID: 8880056
[TBL] [Abstract][Full Text] [Related]
12. Fentanyl inhibits metabolism of midazolam: competitive inhibition of CYP3A4 in vitro.
Oda Y; Mizutani K; Hase I; Nakamoto T; Hamaoka N; Asada A
Br J Anaesth; 1999 Jun; 82(6):900-3. PubMed ID: 10562786
[TBL] [Abstract][Full Text] [Related]
13. Triazolam biotransformation by human liver microsomes in vitro: effects of metabolic inhibitors and clinical confirmation of a predicted interaction with ketoconazole.
von Moltke LL; Greenblatt DJ; Harmatz JS; Duan SX; Harrel LM; Cotreau-Bibbo MM; Pritchard GA; Wright CE; Shader RI
J Pharmacol Exp Ther; 1996 Feb; 276(2):370-9. PubMed ID: 8632299
[TBL] [Abstract][Full Text] [Related]
14. The effects of selective serotonin reuptake inhibitors and their metabolites on S-mephenytoin 4'-hydroxylase activity in human liver microsomes.
Kobayashi K; Yamamoto T; Chiba K; Tani M; Ishizaki T; Kuroiwa Y
Br J Clin Pharmacol; 1995 Nov; 40(5):481-5. PubMed ID: 8703653
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of desipramine hydroxylation in vitro by serotonin-reuptake-inhibitor antidepressants, and by quinidine and ketoconazole: a model system to predict drug interactions in vivo.
von Moltke LL; Greenblatt DJ; Cotreau-Bibbo MM; Duan SX; Harmatz JS; Shader RI
J Pharmacol Exp Ther; 1994 Mar; 268(3):1278-83. PubMed ID: 8138941
[TBL] [Abstract][Full Text] [Related]
16. Cytochrome P4502B6 and 2C9 do not metabolize midazolam: kinetic analysis and inhibition study with monoclonal antibodies.
Hamaoka N; Oda Y; Hase I; Asada A
Br J Anaesth; 2001 Apr; 86(4):540-4. PubMed ID: 11573629
[TBL] [Abstract][Full Text] [Related]
17. Propofol decreases the clearance of midazolam by inhibiting CYP3A4: an in vivo and in vitro study.
Hamaoka N; Oda Y; Hase I; Mizutani K; Nakamoto T; Ishizaki T; Asada A
Clin Pharmacol Ther; 1999 Aug; 66(2):110-7. PubMed ID: 10460064
[TBL] [Abstract][Full Text] [Related]
18. The oxidative metabolism of metoprolol in human liver microsomes: inhibition by the selective serotonin reuptake inhibitors.
Belpaire FM; Wijnant P; Temmerman A; Rasmussen BB; Brøsen K
Eur J Clin Pharmacol; 1998 May; 54(3):261-4. PubMed ID: 9681670
[TBL] [Abstract][Full Text] [Related]
19. Human cytochromes mediating N-demethylation of fluoxetine in vitro.
von Moltke LL; Greenblatt DJ; Duan SX; Schmider J; Wright CE; Harmatz JS; Shader RI
Psychopharmacology (Berl); 1997 Aug; 132(4):402-7. PubMed ID: 9298519
[TBL] [Abstract][Full Text] [Related]
20. Phenacetin O-deethylation by human liver microsomes in vitro: inhibition by chemical probes, SSRI antidepressants, nefazodone and venlafaxine.
von Moltke LL; Greenblatt DJ; Duan SX; Schmider J; Kudchadker L; Fogelman SM; Harmatz JS; Shader RI
Psychopharmacology (Berl); 1996 Dec; 128(4):398-407. PubMed ID: 8986010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
